What is electroCore, Inc. (ECOR) stock price today?

electroCore, Inc. (ECOR) is currently trading at $9.18, down 5.02% today.

What is ECOR P/E ratio?

electroCore, Inc.'s P/E ratio is -5.72. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ECOR return on equity (ROE)?

electroCore, Inc.'s return on equity (ROE) is 524.69%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is electroCore, Inc.'s market cap?

electroCore, Inc. has a market capitalization of $82.72M.

NCM · Medical - Devices

electroCore, Inc. (ECOR) Stock

$9.18 -5.02% NCM: ECOR Healthcare

Valuation

Metric	Value
Price	$9.18
Market Cap	$82.72M
P/E Ratio	-5.72
P/B Ratio	-32.76
P/S Ratio	2.37
EPS (TTM)	$-1.65
52-Week High	$12.70
52-Week Low	$4.41
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	524.69%
ROA	-86.56%
ROCE	-258.13%
Gross Margin	-40.62%
Operating Margin	-40.62%
Net Margin	-39.96%
Debt/Equity	-3.43
Current Ratio	1.09

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$5.0M	$9.0M	$16.0M	$25.0M	$32.0M
Operating Profit	$-20.0M	$-23.0M	$-19.0M	$-12.0M	$-13.0M
Net Profit	$-17.0M	$-22.0M	$-19.0M	$-12.0M	$-14.0M
EPS	$-4.36	$-4.69	$-3.42	$-1.59	$-1.65
Op Margin	-367.7%	-266.2%	-117.3%	-48.3%	-41.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$43.0M	$25.0M	$16.0M	$20.0M	$19.0M
Total Liabilities	$6.0M	$8.0M	$9.0M	$13.0M	$20.0M
Cash	$35.0M	$18.0M	$10.0M	$3.0M	$7.0M
Borrowings	$1.0M	$1.0M	$1.0M	$4.0M	$9.0M

Latest News

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation GlobeNewswire · Jul 16, 2026 iAccess Alpha Virtual Best Ideas Summer Investment Conference Begins Today ACCESS Newswire · Jun 23, 2026 iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026 ACCESS Newswire · Jun 18, 2026 electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference GlobeNewswire · Jun 17, 2026 Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-14.0M	$-17.0M	$-15.0M	$-7.0M	$-8.0M
Investing Cash Flow	$18.0M	$0	$0	$-9.0M	$4.0M
Financing Cash Flow	$0	$0	$-1.0M	$0	$0
Net Cash Flow	$30.0M	$-17.0M	$-7.0M	$-7.0M	$3.0M
Free Cash Flow	$-14.0M	$-17.0M	$-15.0M	$-7.0M	$-8.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	1.38
EV / EBITDA	-7.10
FCF Yield	-11.12%
Quick Ratio	1.00
Interest Coverage	-11.88
Return 1Y	-13.38%
Return 3Y	32.02%
Return 5Y	-60.65%

Ownership

Insiders Held33.33%

Institutions Held8.44%

Institutions Float Held12.66%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	202,644	2026-03-31
Balyasny Asset Management LP	116,463	2026-03-31
Geode Capital Management, LLC	78,083	2026-03-31
Jaffetilchin Investment Partners, LLC	58,198	2026-03-31
Wealthspire Advisors, LLC	47,498	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BTAI	$0.07	+0.00%	-0.02	$2.28M	0.00%
HYPDHyperion DeFi, Inc.	$3.54	+4.07%	-1.19	$53.64M	0.00%
MAIAMAIA Biotechnology, Inc.	$1.17	-4.10%	-1.88	$71.14M	0.00%
MYOMyomo Inc.	$1.41	-1.40%	-5.02	$54.48M	0.00%
NMTCNeuroOne Medical Technologies Corporation	$1.09	-3.12%	-1.23	$9.44M	0.00%

About electroCore, Inc.

electroCore, Inc. is led by CEO Thomas J. Errico, employs 73 people, headquartered in US, publicly traded since 2018.

electroCore, Inc. (ECOR) stock trades at $9.18 with a market capitalization of $82.72M. The stock is valued at a negative price-to-earnings (P/E) ratio of -5.72, reflecting a net loss over the last twelve months, a negative price-to-book of -32.76, reflecting negative shareholders' equity, price-to-sales of 2.37. Over the past 52 weeks the stock has ranged between $4.41 and $12.70, and currently trades 27.7% below its 52-week high.

On profitability, electroCore, Inc. generates a return on equity (ROE) of 524.69% (not meaningful, as shareholders' equity is negative), return on capital employed of -258.13%, an operating margin of -40.62%, a net profit margin of -39.96%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1174.00 -0.45% JNJ Johnson & Johnson $263.00 +0.59% ABBV AbbVie Inc. $280.32 +1.39% MRK Merck & Company, Inc. Common Stock (new) $145.13 -0.33% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.07 -0.59% NVS Novartis AG $143.45 -0.21% AZN AstraZeneca PLC $158.68 -0.33% TMO Thermo Fisher Scientific Inc $655.52 -0.38% AMGN Amgen Inc. $415.39 +0.12% GILD Gilead Sciences, Inc. $150.06 -0.74% ABT Abbott Laboratories $101.25 +1.66% NVO Novo Nordisk A/S $38.49 -0.38%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.